Biogen (BIIB) R&D Expenses & History | Stock Alarm

Demo Sign up Log In

Biogen · R&D Expenses

BIIB R&D Expenses

Latest reported$1.95Bperiod endingJun 30, 2026

BIIB R&D Expenses ($0.00 → $1.95B)

Annual R&D Expenses

High-resolution chart · PNG

BIIB r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	1,954,700,000
Dec 31, 2024	2,488,500,000
Dec 31, 2023	2,702,600,000
Dec 31, 2022	2,597,000,000
Dec 31, 2021	3,400,500,000
Dec 31, 2020	4,530,700,000
Dec 31, 2019	2,770,500,000
Dec 31, 2018	2,709,700,000
Dec 31, 2017	2,373,600,000
Dec 31, 2016	1,973,300,000
Dec 31, 2015	2,012,800,000
Dec 31, 2014	1,893,400,000
Dec 31, 2013	1,455,800,000
Dec 31, 2012	1,378,619,000
Dec 31, 2011	1,219,602,000
Dec 31, 2010	1,248,604,000
Dec 31, 2009	1,283,068,000
Dec 31, 2008	1,072,058,000
Dec 31, 2007	925,164,000
Dec 31, 2006	718,390,000
Dec 31, 2005	747,671,000
Dec 31, 2004	685,872,000
Dec 31, 2003	1,056,337,000
Dec 31, 2002	100,868,000
Dec 31, 2001	314,556,000
Dec 31, 2000	302,840,000
Dec 31, 1999	221,153,000
Dec 31, 1998	177,228,000
Dec 31, 1997	145,501,000
Dec 31, 1996	132,384,000
Dec 31, 1995	87,448,000
Dec 31, 1994	91,213,000
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0
Dec 31, 1989	0
Dec 31, 1988	0
Dec 31, 1987	0
Dec 31, 1986	0
Dec 31, 1985	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.